Abbott Laboratories (ABT) Inventory (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Inventory data on file, last reported at $7.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 5.27% year-over-year to $7.0 billion; the trailing twelve-month figure through Mar 2026 stood at $7.0 billion (up 5.27% YoY), and the FY2025 full-year result was $6.5 billion, up 4.75% from the prior year.
• Inventory grew to $7.0 billion in Q1 2026, from $6.5 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $7.0 billion in Q1 2026 to a low of $5.7 billion in Q1 2022.
• A 5-year average of $6.5 billion and a median of $6.6 billion in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory gained 19.7% in 2022 and retreated 5.72% in 2024, its largest moves.
• Tracing ABT's Inventory over 5 years: stood at $6.2 billion in 2022, then gained by 6.43% to $6.6 billion in 2023, then dropped by 5.72% to $6.2 billion in 2024, then rose by 4.75% to $6.5 billion in 2025, then grew by 7.72% to $7.0 billion in 2026.
• Business Quant data shows ABT's Inventory at $7.0 billion in Q1 2026, $6.5 billion in Q4 2025, and $6.7 billion in Q3 2025.